Skip to content

A Randomized, Single-Blind, Sham-Acupuncture Controlled Trial of Acupuncture for Occipital Neuralgia

A Randomized, Single-Blind, Sham-Acupuncture Controlled Trial of Acupuncture for Occipital Neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001249
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

occipital neuralgia

Interventions

Acupuncture group:Acupuncture
Sham Acupuncture Group:Sham Acupuncture

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for cervicogenic headache. (2) Aged 18–70 years, with no restriction on gender. (3) Disease duration of at least 4 weeks. (4) Average VAS score for cervicogenic headache in the past 4 weeks is greater than or equal to 3. (5) Agrees to participate in the clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Secondary occipital pain caused by definite organic lesions inside and outside the skull (such as tumors, infections), trauma or surgical history in the skull and neck region. (2) Concurrent presence of other types of headaches (such as tension-type headaches, cluster headaches, migraines, etc.). (3) Severe cardiovascular, hepatic, renal, or hematological diseases, or uncontrolled mental disorders. (4) Receipt of acupuncture, local nerve block, surgery, or participation in other clinical trials within the past month. (5) Bleeding tendencies or current use of anticoagulant medications; presence of a cardiac pacemaker; allergy to metal needles or severe needle phobia. (6) Inability or unwillingness to complete headache diaries, assessment scales, and follow-ups as required.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
Frequency and duration of headache attacks;Headache Impact Test -6;Hospital Anxiety and Depression Scale;Patient Global Impression of Change;Therapeutic response ratio;

Countries

China

Contacts

Public Contactzhang kun

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

wuhaibianyuan@163.com19529968272

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026